Demonstrates antioxidant benefits and liver protection in mice using a fermented herbal blend, suggesting a potential treatment for alcohol-induced damage.
Lycium barbarum–Polygonatum cyrtonema composite jiaosu (LBPCJ) was prepared by sequential dual-species fermentation and evaluated in a mouse model of alcohol-induced liver injury. Following process optimization, a yeast-first sequential strategy with intermediate pasteurization was selected, comprising an initial Saccharomyces cerevisiae fermentation step, intermediate pasteurization, and a subsequent Lactiplantibacillus plantarum fermentation step. Fermentation reduced pH from 4.68 to 3.51 and increased total acidity from 61.06 to 135.39 g LA/L and total phenolic content from 3.01 to 9.39 mg GAE/mL. In vitro antioxidant-related activities were also higher after fermentation, with DPPH, ABTS, and •OH scavenging rates increasing by 39.90%, 29.78%, and 11.10%, respectively. In mice, LBPCJ administration was associated with lower liver index and serum aminotransferase levels, together with attenuated hepatic histopathological alterations, with the high-dose group (15 mL/kg BW) showing the clearest response. These changes were accompanied by higher hepatic SOD and GSH levels and lower MDA, TNF-α, IL-1β, and IL-6 levels. LBJ and PCJ also improved several measured indicators, while LBPCJ showed changes across multiple endpoints under the tested conditions. Overall, sequential fermentation markedly altered the physicochemical and antioxidant-related properties of LBPCJ, and LBPCJ administration improved multiple indicators related to alcohol-induced liver injury in mice, although the specific constituents and underlying mechanisms remain to be clarified.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: